SEARCH
SEARCH DIRECTORY
logo
The UK’s integrative cancer care charity■Helpline 0870 163 2990
menu
This window has opened in a new tab in your browser. Your Search Results can still be seen in the original tab. You can keep several tabs open if you wish, or simply close each one as you finish reading it.
Go to Life Directory
Important Information:
Yes to Life's website content is not intended or implied to be a substitute for professional medical advice, nor is it intended to be used for medical diagnosis or treatment. The information is for educational and informational purposes only and has not been reviewed by medical doctors or oncologists. Cancer is a highly complex group of diseases, and it is known to manifest differently in different people, often responding more favourably to individualised approaches to treatment and care. Yes to Life advocates that any person diagnosed with, or suspected of having, cancer, consults with a suitably qualified and experienced medical professional before initiating any type of therapy or supportive treatment. Click here to read our full Disclaimer.
Dr Colin Hopper
Profile:

Dr Colin Hopper BDS, MBBS, MD, FDS, FRCS is a world-leading expert on Photodynamic Therapy (PDT) for cancers of the Head and Neck. He is the founder member/officer of the Head and Neck Optical Diagnostic Society and European Platform for Photodynamic Therapy.

Dr Hopper was elected to President of the International Photodynamic Association for a two-year term in 2023.

Dr Hopper at University College London Hospital is the only clinician in the NHS who offers Photodynamic Therapy for deeper cancers that would otherwise require surgery.



Last Updated:21/04/2024
Report An Error
Location for this provider:
Dr Colin Hopper
University College London, UCL, London, UK - England (South East)

c.hopper@ucl.ac.uk
All therapies provided at this location:
Photodynamic Therapy (PDT)
A photosensitising (light activated) drug is first administered to patients followed by irradiation of cancerous tissue with laser light, which converts the drug into a powerful cytotoxic (cell destroying) agent.

Full Details

Other content on this website featuring this provider:
Radio Show NHS Sidelining PDT 14 Feb 2016